163 related articles for article (PubMed ID: 15894365)
1. Demethylation of the MCJ gene in stage III/IV epithelial ovarian cancer and response to chemotherapy.
Strathdee G; Vass JK; Oien KA; Siddiqui N; Curto-Garcia J; Brown R
Gynecol Oncol; 2005 Jun; 97(3):898-903. PubMed ID: 15894365
[TBL] [Abstract][Full Text] [Related]
2. Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene.
Strathdee G; Davies BR; Vass JK; Siddiqui N; Brown R
Carcinogenesis; 2004 May; 25(5):693-701. PubMed ID: 14729589
[TBL] [Abstract][Full Text] [Related]
3. Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer.
Shridhar V; Bible KC; Staub J; Avula R; Lee YK; Kalli K; Huang H; Hartmann LC; Kaufmann SH; Smith DI
Cancer Res; 2001 May; 61(10):4258-65. PubMed ID: 11358853
[TBL] [Abstract][Full Text] [Related]
4. CpG island methylation of DNA damage response genes in advanced ovarian cancer.
Teodoridis JM; Hall J; Marsh S; Kannall HD; Smyth C; Curto J; Siddiqui N; Gabra H; McLeod HL; Strathdee G; Brown R
Cancer Res; 2005 Oct; 65(19):8961-7. PubMed ID: 16204069
[TBL] [Abstract][Full Text] [Related]
5. High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
Wilcox CB; Baysal BE; Gallion HH; Strange MA; DeLoia JA
Cancer Genet Cytogenet; 2005 Jun; 159(2):114-22. PubMed ID: 15899382
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.
Ahluwalia A; Yan P; Hurteau JA; Bigsby RM; Jung SH; Huang TH; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):261-8. PubMed ID: 11531277
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells.
Ahluwalia A; Hurteau JA; Bigsby RM; Nephew KP
Gynecol Oncol; 2001 Aug; 82(2):299-304. PubMed ID: 11531283
[TBL] [Abstract][Full Text] [Related]
8. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
Wei SH; Chen CM; Strathdee G; Harnsomburana J; Shyu CR; Rahmatpanah F; Shi H; Ng SW; Yan PS; Nephew KP; Brown R; Huang TH
Clin Cancer Res; 2002 Jul; 8(7):2246-52. PubMed ID: 12114427
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
10. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
[TBL] [Abstract][Full Text] [Related]
11. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
[TBL] [Abstract][Full Text] [Related]
12. Microvessel density and CpG island methylation of the THBS2 gene in malignant ovarian tumors.
Czekierdowski A; Czekierdowska S; Danilos J; Czuba B; Sodowski K; Sodowska H; Szymanski M; Kotarski J
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():53-65. PubMed ID: 18955754
[TBL] [Abstract][Full Text] [Related]
13. [Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma].
Zhang J; Ye F; Chen HZ; Ye DF; Lu WG; Xie X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):173-7. PubMed ID: 16733898
[TBL] [Abstract][Full Text] [Related]
14. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.
Czekierdowski A; Czekierdowska S; Szymanski M; Wielgos M; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Oct; 27(5):609-13. PubMed ID: 17159813
[TBL] [Abstract][Full Text] [Related]
15. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
16. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
[TBL] [Abstract][Full Text] [Related]
17. Methylation-controlled J protein promotes c-Jun degradation to prevent ABCB1 transporter expression.
Hatle KM; Neveu W; Dienz O; Rymarchyk S; Barrantes R; Hale S; Farley N; Lounsbury KM; Bond JP; Taatjes D; Rincón M
Mol Cell Biol; 2007 Apr; 27(8):2952-66. PubMed ID: 17283040
[TBL] [Abstract][Full Text] [Related]
18. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer.
Kaneuchi M; Sasaki M; Tanaka Y; Shiina H; Verma M; Ebina Y; Nomura E; Yamamoto R; Sakuragi N; Dahiya R
Biochem Biophys Res Commun; 2004 Apr; 316(4):1156-62. PubMed ID: 15044106
[TBL] [Abstract][Full Text] [Related]
19. [Methylation of the promoter region of the RASSF1A gene, a candidate tumor suppressor, in primary epithelial tumors].
Loginov VI; Maliukova AV; Seregin IuA; Khodyrev DS; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Kiselev LL; Zabarovskiĭ ER; Braga EA
Mol Biol (Mosk); 2004; 38(4):654-67. PubMed ID: 15456137
[TBL] [Abstract][Full Text] [Related]
20. Differential methylation hybridization array of endometrial cancers reveals two novel cancer-specific methylation markers.
Zighelboim I; Goodfellow PJ; Schmidt AP; Walls KC; Mallon MA; Mutch DG; Yan PS; Huang TH; Powell MA
Clin Cancer Res; 2007 May; 13(10):2882-9. PubMed ID: 17504987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
